Vensana Capital
Vensana Capital is a dynamic venture capital and growth equity investment firm committed to transforming healthcare through groundbreaking innovations in medical technology.
Established in 2019, Vensana boasts a robust portfolio, managing $550 million in capital to support visionary entrepreneurs and pioneering companies in the medtech sector.
Focused on advancing development and commercial-stage enterprises, Vensana invests across a diverse range of fields, including medical devices, diagnostics and data science, digital health, life science tools, and tech-enabled services. The firm’s experienced investment team has a proven track record of collaborating with management teams to drive success in industry-leading companies such as Artelon, Cameron Health, CardiAQ, Cartiva, and many more.
At Vensana Capital, the mission is clear: to partner with innovators and help shape the future of healthcare, fostering advancements that enhance patient outcomes and improve medical practices.
